Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer
Clinical trial NCT02534922 · UNKNOWN
Trial details
- NCT number
- NCT02534922
- Sponsor
- Oncolix, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2019-02-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.